… This is a multicentre retrospective study including anti-TNF naïve paediatric CD patients …
dose escalation and the effect of anti-TNF treatment on the growth rate were also evaluated. …

… We performed a retrospective, multicenter, cohort analysis of 44 CD pediatric patients
with moderate–severe CD activity who had been treated with Ifx and were switched to Ada …

… children with Crohn’s disease on adalimumab therapy achieve remission during the first year
of the therapy with reasonable safety … The remaining 13 studies were either retrospective or …

… (5) Study design: randomized controlled trials (RCTs) and retrospective or prospective
cohort studies assessing predefined outcomes; case–control studies and conference abstract …

… However, pediatric data are limited. This study aimed to assess the … and safety of adalimumab
biosimilar (ADL-BioS) in pediatric IBD patients. Methods: All consecutive pediatric IBD …

… In a 2018 retrospective study in Spain, ADL treatment results … personalized anti TNF therapy
in CD study (PANTS) of children … However, this study was conducted retrospectively, and the …

… data suggesting that earlier use of anti-TNF therapy may improve long-term outcomes in
pediatric CD [Citation6]. … The RESEAT trial, a retrospective analysis, showed the use of …

… anti-TNF therapy 1, 2, and 3 years after initiation. Results: In total, 2,464 papers were screened,
94 were selected for full text review… two of these to be retrospective cohort studies [19,20]. …

… ” to anti-TNF therapy (including … pediatric studies: Although 1 previous retrospective study
demonstrated a higher remission rate with ADL combination therapy, 18 another retrospective …

… anti-TNF and TP therapy in pediatric Crohn’s disease. In the IMAgINE 1 study of ADA in
pediatric … [3], while in the RESEAT retrospective analysis of ADA use in pediatric Crohn’s, 41% …